For instance, expression of MYOD1 can predict patient survival in lung cancer patients (Jiang et al., 2015) and high expression of MEF2C is associated with poor outcome in acute myeloid leukemia (AML) patients (Laszlo et al., 2015). The gene discussed is MYOD1; the disease is acute myeloid leukemia.